This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaucher, C.
Right arrow Articles by Fauchere, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaucher, C.
Right arrow Articles by Fauchere, J.-L.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 2000, p. 463-467, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Antibody Response of Patients with Helicobacter pylori-Related Gastric Adenocarcinoma: Significance of Anti-CagA Antibodies

Christine Vaucher,1 Blandine Janvier,2,* Jean-Baptiste Nousbaum,3 Bernadette Grignon,2 Leon Pezennec,2 Michel Robaszkiewicz,3 Herve Gouerou,3 Bertrand Picard,1 and Jean-Louis Fauchere2

Laboratoire de Bactériologie, Faculté de Médecine de Brest-Université de Bretagne occidentale,1 and Service de Hépato-Gastro-Entérologie, CHU La Cavale Blanche,3 29200 Brest, and Laboratoire de Microbiologie A, CHU La Milétrie et Faculté de Médecine et de Pharmacie, 86000 Poitiers,2 France

Received 12 May 1999/Returned for modification 27 July 1999/Accepted 22 February 2000

The aim of this study was to search for a specific antibody pattern in sera from patients suffering from Helicobacter pylori-related gastric adenocarcinoma (GAC). The serological response of 22 patients suffering from GAC, 31 patients with gastroduodenal ulcer, and 39 asymptomatic subjects was analyzed using immunoblotting performed with three H. pylori strains: strain ATCC 43579; strain B110, isolated from a patient with ulcers; and strain B225, isolated from a patient with GAC. In addition, the latex agglutination test Pyloriset Dry was used to analyze ambiguous sera. H. pylori seropositivity was 75% in the GAC group, 61.3% in the ulcer group, and 56.4% in the asymptomatic group. Anti-CagA antibodies were found more often in the GAC group (48.8%) and in the ulcer group (47.3%) than in the asymptomatic group (21.2%). These percentages depended on the strain used as an antigen: in the GAC group, the anti-CagA frequencies were 93.3, 40, and 13.3% with strains B225, B110, and ATCC 43579, respectively. Thus the presence of anti-CagA antibodies was increased in patients suffering from H. pylori-related GAC, in particular when the CagA antigen was from a GAC strain. These data suggest the existence of a CagA protein specifically expressed by H. pylori strains isolated from GAC patients.


* Corresponding author. Mailing address: Laboratoire de Microbiologie A, CHU La Milétrie, 86021 Poitiers Cedex, France. Phone: 33 (5) 49 44 43 53. Fax: 33 (5) 49 44 38 88. E-mail: blandinejanvier{at}hotmail.com.


Clinical and Diagnostic Laboratory Immunology, May 2000, p. 463-467, Vol. 7, No. 3
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • FIGUEROA, G., TRONCOSO, M., TOLEDO, M.S., FAUNDEZ, G., ACUNA, R. (2002). Prevalence of serum antibodies to Helicobacter pylori VacA and CagA and gastric diseases in Chile. J Med Microbiol 51: 300-304 [Abstract] [Full Text]  
  • Figueiredo, C., Quint, W., Nouhan, N., van den Munckhof, H., Herbrink, P., Scherpenisse, J., de Boer, W., Schneeberger, P., Perez-Perez, G., Blaser, M. J., van Doorn, L.-J. (2001). Assessment of Helicobacter pylori vacA and cagA Genotypes and Host Serological Response. J. Clin. Microbiol. 39: 1339-1344 [Abstract] [Full Text]